MAM
Milton, a trailblazer in home essentials announced its strategic partnership with cult.fit
Mumbai: Milton, a trailblazer in home essentials announces its strategic partnership with cult.fit fitness and wellness powerhouse to introduce a line of dynamic colored bottles at cult.fit gyms. Elevating the wellness experience, these iconic bottles will be available at key cult.fit locations in Mumbai, Delhi/NCR, and Bangalore.
Cult.fit, a stalwart in the fitness and wellness domain, serves as India’s premier ecosystem, embracing a diverse community of active paid fitness members. This collaboration symbolises a shared dedication to fostering a healthier lifestyle, where the legacy of Milton, a venerable brand with 50 proud years of history, aligns seamlessly with cult.fit’s ethos.
Recognising Milton as a brand, this collaboration goes beyond products. Customers are invited to explore and acquire the vibrant collection of colored water bottles at cult.fit gyms and conveniently place orders through Milton’s website, all while enjoying exclusive discounts. This partnership transcends the transactional, aiming to weave a narrative of wellness, fitness, and fun, creating a vibrant tapestry for every individual who embraces it.
Expressing excitement about this collaboration, Milton’s spokesperson affirms, “We are thrilled to partner with cult.fit, a brand that shares our unwavering commitment to well-being and hydration. Cult.fit’s extensive influence in the fitness industry makes it the perfect ally for introducing our colored bottle range. These innovative bottles not only ensure hydration during workouts but also empower individuals to infuse a spark of colour into their exercise routine, complementing various looks and adding a personalized touch to the fitness experience.”
In response, cult.fit head of operations Mujtabha Magrey states, “At cult.fit, we value alliances that contribute to community well-being. Milton’s dedication to quality aligns seamlessly with our mission, and their innovative approach adds excitement to our customer’s fitness journey. We infuse fun into fitness at cult.fit, and with Milton’s colored water bottles, we aim to add not just hydration but also a touch of enjoyment to our members’ wellness journey. Cult.fit’s extensive network and loyal fitness community provide an ideal platform to showcase Milton’s latest offerings. Together, we redefine the fitness experience, ensuring it is enjoyable and rewarding for everyone.”
This collaboration exemplifies Milton’s unwavering commitment to offering solutions for everyday wellness essentials. As the first in its category to collaborate with cult.fit, Milton reinforces its dedication to fostering holistic well-being. Cult.fit’s expansive reach and loyal fitness community provide an ideal platform to showcase Milton’s latest offerings, ushering in a new era of innovative and wellness-centric partnerships.
Brands
Sun Pharma to acquire Organon in $11.75 billion deal at $14 per share
Acquisition to create $12.4 billion pharma giant with global scale and biosimilars push
MUMBAI: Sun Pharmaceutical Industries Limited has signed a definitive agreement to acquire Organon & Co. in an all-cash deal valued at $11.75 billion, marking one of the largest cross-border pharma acquisitions by an Indian firm.
Under the terms of the agreement, Organon shareholders will receive $14.00 per share in cash, with Sun Pharma set to acquire 100 per cent of the company’s outstanding shares. The transaction, approved by the boards of both companies, is expected to close in early 2027, subject to regulatory approvals and shareholder consent.
The deal significantly expands Sun Pharma’s global footprint and strengthens its position across women’s health, biosimilars, and branded generics. The combined entity is projected to generate revenues of around $12.4 billion, placing it among the top 25 pharmaceutical companies globally.
Organon, which was spun off from Merck in 2021, brings a portfolio of over 70 products spanning women’s health and general medicines, with operations across more than 140 countries. Its established presence in key markets such as the US, Europe, and China complements Sun Pharma’s existing strengths and growth ambitions.
Sun Pharmaceutical Industries Limited executive chairman Dilip Shanghvi said, “This transaction represents a significant opportunity for Sun Pharma to build on its vision of reaching people and touching lives. Organon’s portfolio, capabilities and global reach are highly complementary to our own.”
Sun Pharmaceutical Industries Limited managing director Kirti Ganorkar added, “This transaction is a logical next step in strengthening Sun Pharma’s global business. Together, we will become a partner of choice for acquiring and launching new products.”
From Organon’s side, Organon & Co. executive chair Carrie Cox noted, “This all-cash transaction offers compelling and immediate value to Organon stockholders, while positioning the business for continued growth under Sun Pharma.”
Strategically, the acquisition gives Sun Pharma entry into the global biosimilars space as a top 10 player and strengthens its innovative medicines portfolio, which is expected to contribute around 27 per cent of combined revenues. The deal is also expected to nearly double EBITDA and cash flow, supporting long-term deleveraging and investment capacity.
Sun Pharma plans to fund the acquisition through a mix of internal accruals and committed financing from global banks, while maintaining focus on disciplined integration and operational continuity post-merger.
If completed as planned, the deal signals a clear shift in India’s pharmaceutical ambitions, from scale at home to leadership on the global stage, with Sun Pharma positioning itself as a more diversified and innovation-led healthcare powerhouse.
